Merck & Co Inc (USD)
MRK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDrug Manufacturers - Major
Day Range84.08 | 85.06
52-Wk Range66.10 | 87.35
Last Close84.68
Mkt Cap (m)216,812.52
Dividend yield2.6%
ISINUS58933Y1055
Volume2,574,778
Exchange VenueNYS

Company Profile

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

Key Information
Price/Earning23.72
Price/Book7.84
Price/Sales5.01
P/CF20.58
Rev Growth (3 year avg)2.31
EPS Growth (3 year avg)0.14
Operating Margin % 21.12
Net Margin %14.71
Return on Equity20.38
Debt/Equity0.94

Legal Documents

Prospectus
en 06/03/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)44,03342,23739,49839,80740,12242,294
Operating Income (m)7,6656,6837,5476,0307,3098,931
Net Income (m)4,40411,9204,4423,9202,3946,220
Basic EPS1.494.121.581.420.882.34
Avg. Diluted Shares Outstanding (m)2,9962,9282,8412,7872,7482,679
Balance Sheet
USD201320142015201620172018
Current Assets (m)35,68533,17329,76430,61424,76625,875
Non Current Assets (m)69,96065,16272,01564,76363,10656,762
Total Assets (m)105,64598,335101,77995,37787,87282,637
Current Liabilities (m)17,86818,76619,20317,20418,61422,206
Total Liabilities (m)------
Total Equity (m)49,76548,64744,67640,08834,33626,701
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)11,6547,86012,42110,3766,44710,922
Capital Expenditure (m)-1,548-2,317-1,283-1,614-1,888-2,615
Figures are quoted in USD unless stated otherwise
-0.15 (-0.18%)
$
84.53
Last Price